Literature DB >> 2226789

The functional properties of full length and mutant chicken gizzard smooth muscle caldesmon expressed in Escherichia coli.

C S Redwood1, S B Marston, J Bryan, R A Cross, J Kendrick-Jones.   

Abstract

Wild type chicken gizzard caldesmon (756 amino acids) was expressed in a T7 RNA polymerase-based bacterial expression system at a yield of 1 mg pure caldesmon per litre bacterial culture. A mutant composed of amino acids 1-578 was also constructed and expressed. The wild type and mutant caldesmon were purified and compared with native chicken gizzard caldesmon. Native and wild type expressed caldesmon were indistinguishable in assays for inhibition of actin-tropomyosin activation of myosin ATPase, reversal of inhibition by Ca2(+)-calmodulin and binding to actin, actin-tropomyosin, Ca2(+)-calmodulin, tropomyosin and myosin. The mutant missing the C-terminal 178 amino acids had no inhibitory effect and did not bind to actin or Ca2(+)-calmodulin. It bound to tropomyosin with a 5-fold reduced affinity and to myosin with a greater than 10-fold reduced affinity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226789     DOI: 10.1016/0014-5793(90)81233-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 2.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

3.  Identification of functioning regulatory sites and a new myosin binding site in the C-terminal 288 amino acids of caldesmon expressed from a human clone.

Authors:  P A Huber; C S Redwood; N D Avent; M J Tanner; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

4.  Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

Authors:  N V Bogatcheva; A V Vorotnikov; K G Birukov; V P Shirinsky; N B Gusev
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  Phosphorylation of aorta caldesmon by endogenous proteolytic fragments of protein kinase C.

Authors:  A V Vorotnikov; N B Gusev; S Hua; J H Collins; C S Redwood; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1994-02       Impact factor: 2.698

6.  Location of smooth-muscle myosin and tropomyosin binding sites in the C-terminal 288 residues of human caldesmon.

Authors:  P A Huber; I D Fraser; S B Marston
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

7.  Overexpression, purification, and characterization of full-length and mutant caldesmons using a baculovirus expression system.

Authors:  Z Wang; K Y Horiuchi; S S Jacob; S Gopalakurup; S Chacko
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

8.  Caldesmon content of mammalian smooth muscles.

Authors:  J R Haeberle; D R Hathaway; C L Smith
Journal:  J Muscle Res Cell Motil       Date:  1992-02       Impact factor: 2.698

9.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.